Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (101-110 of 222) with videos related to

Pageof 23
Sort By:
Anticancer Research|May 13, 2015
Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder CancerThorsten H Ecke, Christian Arndt, Carsten Stephan, et al.
Histology and Histopathology|April 9, 2010
Diagnostic and prognostic value of T-cell receptor gamma alternative reading frame protein (TARP) expression in prostate cancerFlorian R Fritzsche, Carsten Stephan, Josefine Gerhardt, et al.
ISRN Urology|July 26, 2012
External validation of an artificial neural network and two nomograms for prostate cancer detectionThorsten H Ecke, Steffen Hallmann, Stefan Koch, et al.
Cancer Medicine|September 8, 2017
miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomyThorsten H Ecke, Katja Stier, Sabine Weickmann, et al.
Anticancer Research|July 26, 2007
Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancerCarsten Stephan, Hellmuth-Alexander Meyer, Eva-Maria Paul, et al.
Urology|February 27, 2007
Electrophoretic subforms of free prostate-specific antigen in serum as promising diagnostic tool in prostate cancer diagnosticsKlaus Jung, Wolfgang Hoesel, Jeanett Reiche, et al.
Plos One|October 12, 2012
Selenoprotein P status correlates to cancer-specific mortality in renal cancer patientsHellmuth A Meyer, Tobias Endermann, Carsten Stephan, et al.
The Prostate|October 23, 2008
A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseasesCarsten Stephan, Anna-Maria Kahrs, Henning Cammann, et al.
European Urology|July 13, 2004
Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8-16Monika Jung, Chuanliang Xu, Jan Spethmann, et al.
BJU International|March 31, 2015
The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 yearsMartin Boegemann, Carsten Stephan, Henning Cammann, et al.
Pageof 23

Showing results (101-110 of 222) with videos related to

Sort By:
Pageof 23
Anticancer Research|May 13, 2015
Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder CancerThorsten H Ecke, Christian Arndt, Carsten Stephan, et al.
Histology and Histopathology|April 9, 2010
Diagnostic and prognostic value of T-cell receptor gamma alternative reading frame protein (TARP) expression in prostate cancerFlorian R Fritzsche, Carsten Stephan, Josefine Gerhardt, et al.
ISRN Urology|July 26, 2012
External validation of an artificial neural network and two nomograms for prostate cancer detectionThorsten H Ecke, Steffen Hallmann, Stefan Koch, et al.
Cancer Medicine|September 8, 2017
miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomyThorsten H Ecke, Katja Stier, Sabine Weickmann, et al.
Anticancer Research|July 26, 2007
Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancerCarsten Stephan, Hellmuth-Alexander Meyer, Eva-Maria Paul, et al.
Urology|February 27, 2007
Electrophoretic subforms of free prostate-specific antigen in serum as promising diagnostic tool in prostate cancer diagnosticsKlaus Jung, Wolfgang Hoesel, Jeanett Reiche, et al.
Plos One|October 12, 2012
Selenoprotein P status correlates to cancer-specific mortality in renal cancer patientsHellmuth A Meyer, Tobias Endermann, Carsten Stephan, et al.
The Prostate|October 23, 2008
A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseasesCarsten Stephan, Anna-Maria Kahrs, Henning Cammann, et al.
European Urology|July 13, 2004
Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8-16Monika Jung, Chuanliang Xu, Jan Spethmann, et al.
BJU International|March 31, 2015
The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 yearsMartin Boegemann, Carsten Stephan, Henning Cammann, et al.
Pageof 23